Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Khaberni - The human intestine harbors over 100 trillion microorganisms, performing functions far beyond digestion, extending ...

In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the Clinical-Grade, ...

Board of Alders New Haven Notice] The Joint Community Development/Health & Human Services Committee will meet in person on Wednesday, April 15, 2026, at 6:00 P.M, in the Board of Alders Chamber, 165 ...

HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

Early data suggests single-infusion treatment can safely reprogram immune cells inside the body, opening doors to more ...

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...